Determination of threshold energy dose for ultrasound-induced transdermal drug transport

被引:123
作者
Mitragotri, S [1 ]
Farrell, J [1 ]
Tang, H [1 ]
Terahara, T [1 ]
Kost, J [1 ]
Langer, R [1 ]
机构
[1] MIT, Cambridge, MA 02139 USA
关键词
sonophoresis; cavitation; transdermal; drug delivery; ultrasound dose;
D O I
10.1016/S0168-3659(99)00178-9
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Low-frequency (20 kHz) ultrasound has been shown to enhance transdermal transport of drugs, a phenomenon referred to as sonophoresis. In this paper, we report the threshold energy dose for ultrasound-induced transdermal drug transport. The threshold was determined by in vitro measurements of the dependence of sonophoretic enhancement on ultrasound parameters, including intensity, duty cycle, and exposure time. While the enhancement varies linearly with ultrasound intensity and exposure times, it is independent of the duty cycle in the range of parameters studied. The enhancement is also directly proportional to the ultrasound energy density once the threshold value is crossed. For full thickness pig skin, the threshold value is about 222 J/cm(2). The overall dependence of transport enhancement on ultrasound parameters is similar to that of cavitation measured in a model system, pitting of aluminum foil. Specifically, the extent of pitting is proportional to ultrasound intensity and exposure time and is independent of duty cycle. Furthermore, the extent of pitting is also proportional to the ultrasound energy density. The similarity between the parametric dependence of transport enhancement and cavitation is consistent with previous findings that cavitation plays the dominant role in sonophoresis. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:41 / 52
页数:12
相关论文
共 22 条
[1]  
[Anonymous], 1988, ULTRASOUND ITS CHEM
[2]  
BASURI L, 1962, J PHYSL, V160, P513
[3]   USE OF ULTRASOUND TO ENHANCE PERCUTANEOUS-ABSORPTION OF BENZYDAMINE [J].
BENSON, HAE ;
MCELNAY, JC ;
HARLAND, R .
PHYSICAL THERAPY, 1989, 69 (02) :113-118
[4]   SONOPHORESIS .2. EXAMINATION OF THE MECHANISM(S) OF ULTRASOUND-ENHANCED TRANSDERMAL DRUG DELIVERY [J].
BOMMANNAN, D ;
MENON, GK ;
OKUYAMA, H ;
ELIAS, PM ;
GUY, RH .
PHARMACEUTICAL RESEARCH, 1992, 9 (08) :1043-1047
[5]   SONOPHORESIS .1. THE USE OF HIGH-FREQUENCY ULTRASOUND TO ENHANCE TRANSDERMAL DRUG DELIVERY [J].
BOMMANNAN, D ;
OKUYAMA, H ;
STAUFFER, P ;
GUY, RH .
PHARMACEUTICAL RESEARCH, 1992, 9 (04) :559-564
[6]  
BRONAUGH RL, 1989, PERCUTANEOUS ABSORPT, P1
[7]  
FARRELL J, 1998, ANN M AC SOC AM
[8]  
Frederick J. R., 1980, ULTRASOUND ENG
[9]   THRESHOLD DOSAGES FOR DAMAGE TO MAMMALIAN LIVER BY HIGH-INTENSITY FOCUSED ULTRASOUND [J].
FRIZZELL, LA .
IEEE TRANSACTIONS ON ULTRASONICS FERROELECTRICS AND FREQUENCY CONTROL, 1988, 35 (05) :578-581
[10]   THRESHOLDS FOR FOCAL ULTRASONIC LESIONS IN RABBIT KIDNEY, LIVER AND TESTICLE [J].
FRIZZELL, LA ;
LINKE, CA ;
CARSTENSEN, EL ;
FRIDD, CW .
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 1977, 24 (04) :393-396